Hypolipidemic effect of beraprost sodium in patients with arterioisclerosis obliterans accompanied by hyperlipidemia
- Author
- HAYASHI, K1 ; OHTANI, H1 ; OKURA, Y1 ; TANAKA, K1 ; YASUNOBU, Y1 ; MIZUNO, T1 ; FUJIYAMA, M1 ; KAMBE, M; KAJIYAMA, G1
[1] Hiroshima univ. school medicine, first dep. internal medicine, Minami-ku, Hiroshima 734, Japan - Source
Current therapeutic research. 1994, Vol 55, Num 12, pp 1486-1491 ; ref : 10 ref
- CODEN
- CTCEA9
- ISSN
- 0011-393X
- Scientific domain
- Pharmacology drugs
- Publisher
- Excerpta medica, Belle Mead, NJ
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Apolipoprotéine Arachidonique acide dérivé Athérosclérose Béraprost Chimiothérapie Cholestérol Homme Hyperlipémie Hypolipémiant Lipide Lipoprotéine Lipémie Prostaglandine I2 Traitement Appareil circulatoire pathologie Métabolisme pathologie Vaisseau sanguin pathologie
- Keyword (en)
- Apolipoproteins Arachidonic acid derivatives Atherosclerosis Chemotherapy Cholesterol Human Hyperlipemia Antilipemic agent Lipids Lipoprotein Lipemia Prostaglandin I2 Treatment Cardiovascular disease Metabolic diseases Vascular disease
- Keyword (es)
- Apolipoproteína Araquidónico ácido derivado Ateroesclerosis Quimioterapia Colesterol Hombre Hiperlipemia Hipolipemiante Lípido Lipoproteina Lipemia Prostaglandina I2 Tratamiento Aparato circulatorio patología Metabolismo patología Vaso sanguíneo patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02N General and cellular metabolism. Vitamins
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 3376139
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/S0011-393X(05)80756-8 
https://dx.doi.org/10.1016/S0011-393X(05)80756-8
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0011-393X(05)80756-8\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:116:\"Hypolipidemic effect of beraprost sodium in patients with arterioisclerosis obliterans accompanied by hyperlipidemia\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Current therapeutic research\";s:9:\"\u0000*\u0000stitle\";s:15:\"Curr. ther. res\";s:7:\"\u0000*\u0000date\";s:4:\"1994\";s:9:\"\u0000*\u0000volume\";s:2:\"55\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"1486\";s:8:\"\u0000*\u0000epage\";s:4:\"1491\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0011-393X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"HAYASHI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"K\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:9:\"OHTANI, H\";i:1;s:8:\"OKURA, Y\";i:2;s:9:\"TANAKA, K\";i:3;s:11:\"YASUNOBU, Y\";i:4;s:9:\"MIZUNO, T\";i:5;s:11:\"FUJIYAMA, M\";i:6;s:8:\"KAMBE, M\";i:7;s:11:\"KAJIYAMA, G\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CTCEA9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:116:\"Hypolipidemic effect of beraprost sodium in patients with arterioisclerosis obliterans accompanied by hyperlipidemia\";s:8:\"\u0000*\u0000place\";s:14:\"Belle Mead, NJ\";s:6:\"\u0000*\u0000pub\";s:15:\"Excerpta medica\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0011-393X(05)80756-8\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:116:\"Hypolipidemic effect of beraprost sodium in patients with arterioisclerosis obliterans accompanied by hyperlipidemia\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Current therapeutic research\";s:9:\"\u0000*\u0000stitle\";s:15:\"Curr. ther. res\";s:7:\"\u0000*\u0000date\";s:4:\"1994\";s:9:\"\u0000*\u0000volume\";s:2:\"55\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"1486\";s:8:\"\u0000*\u0000epage\";s:4:\"1491\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0011-393X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"HAYASHI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"K\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:9:\"OHTANI, H\";i:1;s:8:\"OKURA, Y\";i:2;s:9:\"TANAKA, K\";i:3;s:11:\"YASUNOBU, Y\";i:4;s:9:\"MIZUNO, T\";i:5;s:11:\"FUJIYAMA, M\";i:6;s:8:\"KAMBE, M\";i:7;s:11:\"KAJIYAMA, G\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CTCEA9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:116:\"Hypolipidemic effect of beraprost sodium in patients with arterioisclerosis obliterans accompanied by hyperlipidemia\";s:8:\"\u0000*\u0000place\";s:14:\"Belle Mead, NJ\";s:6:\"\u0000*\u0000pub\";s:15:\"Excerpta medica\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0011-393X(05)80756-8\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0011-393X(05)80756-8\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:116:\"Hypolipidemic effect of beraprost sodium in patients with arterioisclerosis obliterans accompanied by hyperlipidemia\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Current therapeutic research\";s:9:\"\u0000*\u0000stitle\";s:15:\"Curr. ther. res\";s:7:\"\u0000*\u0000date\";s:4:\"1994\";s:9:\"\u0000*\u0000volume\";s:2:\"55\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"1486\";s:8:\"\u0000*\u0000epage\";s:4:\"1491\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0011-393X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"HAYASHI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"K\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:9:\"OHTANI, H\";i:1;s:8:\"OKURA, Y\";i:2;s:9:\"TANAKA, K\";i:3;s:11:\"YASUNOBU, Y\";i:4;s:9:\"MIZUNO, T\";i:5;s:11:\"FUJIYAMA, M\";i:6;s:8:\"KAMBE, M\";i:7;s:11:\"KAJIYAMA, G\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CTCEA9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:116:\"Hypolipidemic effect of beraprost sodium in patients with arterioisclerosis obliterans accompanied by hyperlipidemia\";s:8:\"\u0000*\u0000place\";s:14:\"Belle Mead, NJ\";s:6:\"\u0000*\u0000pub\";s:15:\"Excerpta medica\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0011-393X(05)80756-8\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:116:\"Hypolipidemic effect of beraprost sodium in patients with arterioisclerosis obliterans accompanied by hyperlipidemia\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Current therapeutic research\";s:9:\"\u0000*\u0000stitle\";s:15:\"Curr. ther. res\";s:7:\"\u0000*\u0000date\";s:4:\"1994\";s:9:\"\u0000*\u0000volume\";s:2:\"55\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"1486\";s:8:\"\u0000*\u0000epage\";s:4:\"1491\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0011-393X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"HAYASHI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"K\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:9:\"OHTANI, H\";i:1;s:8:\"OKURA, Y\";i:2;s:9:\"TANAKA, K\";i:3;s:11:\"YASUNOBU, Y\";i:4;s:9:\"MIZUNO, T\";i:5;s:11:\"FUJIYAMA, M\";i:6;s:8:\"KAMBE, M\";i:7;s:11:\"KAJIYAMA, G\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CTCEA9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:116:\"Hypolipidemic effect of beraprost sodium in patients with arterioisclerosis obliterans accompanied by hyperlipidemia\";s:8:\"\u0000*\u0000place\";s:14:\"Belle Mead, NJ\";s:6:\"\u0000*\u0000pub\";s:15:\"Excerpta medica\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0011-393X(05)80756-8\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:116:\"Hypolipidemic effect of beraprost sodium in patients with arterioisclerosis obliterans accompanied by hyperlipidemia\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Current therapeutic research\";s:9:\"\u0000*\u0000stitle\";s:15:\"Curr. ther. res\";s:7:\"\u0000*\u0000date\";s:4:\"1994\";s:9:\"\u0000*\u0000volume\";s:2:\"55\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"1486\";s:8:\"\u0000*\u0000epage\";s:4:\"1491\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0011-393X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"HAYASHI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"K\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:9:\"OHTANI, H\";i:1;s:8:\"OKURA, Y\";i:2;s:9:\"TANAKA, K\";i:3;s:11:\"YASUNOBU, Y\";i:4;s:9:\"MIZUNO, T\";i:5;s:11:\"FUJIYAMA, M\";i:6;s:8:\"KAMBE, M\";i:7;s:11:\"KAJIYAMA, G\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CTCEA9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:116:\"Hypolipidemic effect of beraprost sodium in patients with arterioisclerosis obliterans accompanied by hyperlipidemia\";s:8:\"\u0000*\u0000place\";s:14:\"Belle Mead, NJ\";s:6:\"\u0000*\u0000pub\";s:15:\"Excerpta medica\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
